BrightSpring Q4 Revenue Jumps 29.3% to $3.55B; 2026 Revenue Guidance $14.45–$15B
BrightSpring reported Q4 net revenue of $3.551 billion, up 29.3% year-over-year, and adjusted EBITDA of $184 million, a 40.7% increase. Full-year 2025 revenue reached $12.911 billion, net income was $104.8 million versus a $68.9 million loss, and 2026 guidance forecasts $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA.
1. Fourth Quarter 2025 Financial Results
BrightSpring reported net revenue of $3.551 billion in Q4 2025, a 29.3% increase from $2.747 billion a year earlier. Gross profit rose 21.8% to $413 million, net income surged to $49.6 million from $4.3 million, adjusted EBITDA jumped 40.7% to $184 million, and the company acquired 107 branches while repurchasing 1.5 million shares for $43.2 million.
2. Full-Year 2025 Performance
Continuing operations generated $12.911 billion in revenue for full-year 2025, up 28.2% from $10.072 billion in 2024, with gross profit increasing 19.8% to $1.518 billion. Net income turned positive at $104.8 million versus a $68.9 million loss, operating cash flow reached $490 million, adjusted EBITDA rose 34.2% to $618 million, and leverage improved to 2.99x.
3. 2026 Financial Guidance
For 2026, the company projects revenue of $14.45–$15.0 billion, representing 11.9%–16.2% growth, with the pharmacy segment expected at $12.6–$13.1 billion and provider services at $1.85–$1.9 billion. Total adjusted EBITDA guidance is $760–$790 million, including approximately $30 million contribution from recent acquisitions, excluding the Community Living business.